↓ Skip to main content

Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis

Overview of attention for article published in Oncotarget, March 2015
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
152 Dimensions

Readers on

mendeley
162 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis
Published in
Oncotarget, March 2015
DOI 10.18632/oncotarget.3730
Pubmed ID
Authors

Xi Feng, Frank Szulzewsky, Alexan Yerevanian, Zhihong Chen, David Heinzmann, Rikke Darling Rasmussen, Virginia Alvarez-Garcia, Yeonghwan Kim, Bingcheng Wang, Ilaria Tamagno, Hao Zhou, Xiaoxia Li, Helmut Kettenmann, Richard M. Ransohoff, Dolores Hambardzumyan

Abstract

The most abundant populations of non-neoplastic cells in the glioblastoma (GBM) microenvironment are resident microglia, macrophages and infiltrating monocytes from the blood circulation. The mechanisms by which monocytes infiltrate into GBM, their fate following infiltration, and their role in GBM growth are not known. Here we tested the hypothesis that loss of the fractalkine receptor CX3CR1 in microglia and monocytes would affect gliomagenesis. Deletion of Cx3cr1 from the microenvironment resulted in increased tumor incidence and shorter survival times in glioma-bearing mice. Loss of Cx3cr1 did not affect accumulation of microglia/macrophages in peri-tumoral areas, but instead indirectly promoted the trafficking of CD11b+CD45hiCX3CR1lowLy-6ChiLy-6G-F4/80-/low circulating inflammatory monocytes into the CNS, resulting in their increased accumulation in the perivascular area. Cx3cr1-deficient microglia/macrophages and monocytes demonstrated upregulation of IL1β expression that was inversely proportional to Cx3cr1 gene dosage. The Proneural subgroup of the TCGA GBM patient dataset with high IL1β expression showed shorter survival compared to patients with low IL1β. IL1β promoted tumor growth and increased the cancer stem cell phenotype in murine and human Proneural glioma stem cells (GSCs). IL1β activated the p38 MAPK signaling pathway and expression of monocyte chemoattractant protein (MCP-1/CCL2) by tumor cells. Loss of Cx3cr1 in microglia in a monocyte-free environment had no impact on tumor growth and did not alter microglial migration. These data suggest that enhancing signaling to CX3CR1 or inhibiting IL1β signaling in intra-tumoral macrophages can be considered as potential strategies to decrease the tumor-promoting effects of monocytes in Proneural GBM.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 161 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 38 23%
Researcher 22 14%
Student > Bachelor 20 12%
Student > Master 16 10%
Student > Doctoral Student 15 9%
Other 19 12%
Unknown 32 20%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 27 17%
Medicine and Dentistry 26 16%
Neuroscience 23 14%
Agricultural and Biological Sciences 19 12%
Immunology and Microbiology 10 6%
Other 15 9%
Unknown 42 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2016.
All research outputs
#18,445,779
of 22,854,458 outputs
Outputs from Oncotarget
#8,440
of 14,325 outputs
Outputs of similar age
#192,970
of 263,846 outputs
Outputs of similar age from Oncotarget
#300
of 529 outputs
Altmetric has tracked 22,854,458 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 14,325 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,846 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 529 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.